comparemela.com

Page 8 - Douglase Onsi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Leap Therapeutics to Present Initial Data from the Investigator-Sponsored Study of DKN-01 Plus Docetaxel in Patients with Prostate Cancer at the 2022 ASCO Annual Meeting

/PRNewswire/ Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today.

United statesUnited kingdomNew zealandMatthew deyoungDavid wiseDouglase onsiOncologist at perlmutter cancer centerLangone healthAmerican society of clinical oncologyBeigene ltdPrnewswire leap therapeutics incSecurities exchangeLeap therapeutics incPerlmutter cancer centerClinical oncologyAnnual meeting

Leap Therapeutics Reports First Quarter 2022 Financial Results

/PRNewswire/ Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported.

New yorkUnited statesUnited kingdomNew zealandMatthew deyoungLeica biosystemsDavid wiseDouglase onsiAmerican society of clinical oncologyBeigene ltdPartnership on companionLangone medical centerPrnewswire leap therapeutics incSecurities exchangeLeap therapeutics incDavid wise of new york university

Leap Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results

/PRNewswire/ Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported.

United kingdomNew zealandMatthew deyoungLeica biosystemsDouglase onsiBeigene ltdPartnership on companionPrnewswire leap therapeutics incSecurities exchangeLeap therapeutics incSociety of gynecologic oncologyDistinguish studyGynecologic oncologyChief executive officerPublic offeringCommon stock

Leap Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results

/PRNewswire/ Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported.

United kingdomNew zealandMatthew deyoungLeica biosystemsDouglase onsiBeigene ltdPartnership on companionPrnewswire leap therapeutics incSecurities exchangeLeap therapeutics incSociety of gynecologic oncologyDistinguish studyGynecologic oncologyChief executive officerPublic offeringCommon stock

Leap Therapeutics to Present at Raymond James 43rd Annual Institutional Investors Conference

/PRNewswire/ Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today.

United kingdomNew zealandMatthew deyoungDouglase onsiPrnewswire leap therapeutics incSecurities exchangeBeigene ltdLeap therapeutics incChief executive officerRaymond james institutional investors conferencePresentation detailsLeap therapeuticsSecurities actSecurities exchange actPrivate securities litigation reform actLeap therapeutics

vimarsana © 2020. All Rights Reserved.